We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$616B
AUM Growth
+$31B
Cap. Flow
-$1.19B
Cap. Flow %
-0.19%
Top 10 Hldgs %
18.88%
Holding
2,692
New
121
Increased
947
Reduced
1,282
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.86B
2
VMW
VMware, Inc
VMW
+$1.49B
3
AVGO icon
Broadcom
AVGO
+$1.29B
4
SRE icon
Sempra
SRE
+$1.26B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Healthcare 17.07%
2 Financials 16.19%
3 Technology 16.15%
4 Consumer Discretionary 13.93%
5 Industrials 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMBA icon
1251
Ambarella
AMBA
$3.66B
$16M ﹤0.01%
+271,650
New +$15.1M
MSEX icon
1252
Middlesex Water
MSEX
$1.1B
$16M ﹤0.01%
399,794
+51,680
+15% +$2.23M
RGEN icon
1253
Repligen
RGEN
$9.45B
$15.9M ﹤0.01%
438,885
+2,267
+0.5% +$82.1K
SCL icon
1254
Stepan Co
SCL
$1.48B
$15.9M ﹤0.01%
201,427
+6,368
+3% +$523K
PDCE
1255
DELISTED
PDC Energy, Inc.
PDCE
$15.8M ﹤0.01%
306,125
-1,319
-0.4% -$62.5K
LBRDA icon
1256
Liberty Broadband Class A
LBRDA
$5.07B
$15.7M ﹤0.01%
184,517
-25,615
-12% -$2.26M
VER
1257
DELISTED
VEREIT, Inc.
VER
$15.5M ﹤0.01%
398,930
-6,554,996
-94% -$263M
PAHC icon
1258
Phibro Animal Health
PAHC
$1.37B
$15.5M ﹤0.01%
462,196
+15,827
+4% +$562K
HBI
1259
DELISTED
Hanesbrands
HBI
$15.3M ﹤0.01%
731,360
-145,436
-17% -$3.11M
TCPC icon
1260
BlackRock TCP Capital
TCPC
$336M
$15.2M ﹤0.01%
996,483
-42,800
-4% -$685K
HCCI
1261
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$15.2M ﹤0.01%
+698,335
New +$14.1M
NTUS
1262
DELISTED
Natus Medical Inc
NTUS
$15.2M ﹤0.01%
397,085
-91,401
-19% -$3.65M
XOXO
1263
DELISTED
Xo Group Inc
XOXO
$15M ﹤0.01%
815,197
-231,005
-22% -$4.49M
AMD icon
1264
Advanced Micro Devices
AMD
$789B
$15M ﹤0.01%
1,462,544
+32,600
+2% +$381K
QRVO icon
1265
Qorvo
QRVO
$8.67B
$14.9M ﹤0.01%
224,058
-100
-0% -$7.29K
WU icon
1266
Western Union
WU
$2.34B
$14.9M ﹤0.01%
782,142
-76,100
-9% -$1.49M
HOG icon
1267
Harley-Davidson
HOG
$2.7B
$14.8M ﹤0.01%
290,702
-53,800
-16% -$2.62M
EAT icon
1268
Brinker International
EAT
$10.2B
$14.8M ﹤0.01%
380,281
-1,539
-0.4% -$53.1K
JBSS icon
1269
John B. Sanfilippo & Son
JBSS
$989M
$14.8M ﹤0.01%
233,306
-4,045
-2% -$254K
LTRPA
1270
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$14.6M ﹤0.01%
1,546,595
-3,983,407
-72% -$40.9M
SNAP icon
1271
Snap
SNAP
$8.96B
$14.6M ﹤0.01%
996,450
-2,196,571
-69% -$32M
SNI
1272
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$14.5M ﹤0.01%
170,379
CVS icon
1273
CALL
CVS Health
CVS
$121B
$14.5M ﹤0.01%
200,000
TPGE.U
1274
DELISTED
TPG Pace Energy Holdings Corp.
TPGE.U
$14.4M ﹤0.01%
1,411,659
+372
+0% +$3.8K
SFE
1275
DELISTED
Safeguard Scientifics, Inc.
SFE
$14.4M ﹤0.01%
1,281,401
-65,200
-5% -$835K

Similar funds

T. Rowe Price Associates's Q4 2017 Portfolio in Review

As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
  • T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
  • T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
  • T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
  • T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
  • T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.

Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.